DK0975640T3 - Antimitotiske halogenderivater af vinka-alkaloider - Google Patents

Antimitotiske halogenderivater af vinka-alkaloider

Info

Publication number
DK0975640T3
DK0975640T3 DK98920607T DK98920607T DK0975640T3 DK 0975640 T3 DK0975640 T3 DK 0975640T3 DK 98920607 T DK98920607 T DK 98920607T DK 98920607 T DK98920607 T DK 98920607T DK 0975640 T3 DK0975640 T3 DK 0975640T3
Authority
DK
Denmark
Prior art keywords
antimitotic
halogen derivatives
formula
preparation
vinka alkaloids
Prior art date
Application number
DK98920607T
Other languages
English (en)
Inventor
Alain Duflos
Jacques Fahy
Du Boulay Valerie Thillaye
Jean-Marc Barret
Bridget Hill
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK0975640T3 publication Critical patent/DK0975640T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK98920607T 1997-04-10 1998-04-10 Antimitotiske halogenderivater af vinka-alkaloider DK0975640T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704398A FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca

Publications (1)

Publication Number Publication Date
DK0975640T3 true DK0975640T3 (da) 2004-11-01

Family

ID=9505731

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06124480.2T DK1764368T3 (da) 1997-04-10 1998-04-10 Antimototisk halogeneret derivat af vincaalkaloid
DK98920607T DK0975640T3 (da) 1997-04-10 1998-04-10 Antimitotiske halogenderivater af vinka-alkaloider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06124480.2T DK1764368T3 (da) 1997-04-10 1998-04-10 Antimototisk halogeneret derivat af vincaalkaloid

Country Status (15)

Country Link
US (1) US6127377A (da)
EP (3) EP1357125A3 (da)
JP (3) JP4401440B2 (da)
AT (2) ATE473987T1 (da)
AU (1) AU737549C (da)
BR (2) BR9807944B1 (da)
CA (3) CA2455416C (da)
CY (2) CY1111476T1 (da)
DE (3) DE122010000054I1 (da)
DK (2) DK1764368T3 (da)
ES (2) ES2222588T3 (da)
FR (2) FR2761990B1 (da)
LU (1) LU91769I2 (da)
PT (2) PT975640E (da)
WO (1) WO1998045301A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
WO2005055943A2 (en) * 2003-12-04 2005-06-23 Amr Technology, Inc. Vinorelbine derivatives
WO2005055939A2 (en) * 2003-12-04 2005-06-23 Amr Technology, Inc. Vinca derivatives
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
EP1883627B1 (en) 2005-05-18 2018-04-18 Pharmascience Inc. Bir domain binding compounds
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
AU2007250443B2 (en) 2006-05-16 2013-06-13 Pharmascience Inc. IAP BIR domain binding compounds
WO2008033935A2 (en) * 2006-09-12 2008-03-20 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
DE102010020994B4 (de) * 2010-01-27 2022-01-27 Interpane Entwicklungs-Und Beratungsgesellschaft Mbh Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen
ES2625637T3 (es) 2010-02-12 2017-07-20 Pharmascience Inc. Compuestos de unión al dominio BIR IAP
WO2011103007A2 (en) * 2010-02-22 2011-08-25 The Scripps Research Institute 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca

Also Published As

Publication number Publication date
DK1764368T3 (da) 2010-10-18
CA2665949C (fr) 2013-06-11
BR9807944B1 (pt) 2011-02-08
BR9816177B1 (pt) 2010-08-24
AU737549B2 (en) 2001-08-23
US6127377A (en) 2000-10-03
JP4307292B2 (ja) 2009-08-05
ATE270297T1 (de) 2004-07-15
CA2286560A1 (fr) 1998-10-15
FR10C0045I1 (da) 2010-10-29
JP2009167196A (ja) 2009-07-30
DE69824840T2 (de) 2005-07-21
AU737549C (en) 2002-03-28
FR10C0045I2 (fr) 2011-04-29
BR9807944A (pt) 2000-03-08
DE69824840D1 (de) 2004-08-05
CY2010019I2 (el) 2012-01-25
AU7340898A (en) 1998-10-30
CY1111476T1 (el) 2012-01-25
PT1764368E (pt) 2010-09-16
CY2010019I1 (el) 2012-01-25
EP1764368B1 (fr) 2010-07-14
EP1357125A3 (fr) 2003-11-26
CA2286560C (fr) 2009-09-08
JP4401440B2 (ja) 2010-01-20
ATE473987T1 (de) 2010-07-15
EP1357125A2 (fr) 2003-10-29
JP2004277418A (ja) 2004-10-07
DE69841766D1 (de) 2010-08-26
PT975640E (pt) 2004-11-30
FR2761990B1 (fr) 1999-06-25
CA2455416A1 (fr) 1998-10-15
JP2001518892A (ja) 2001-10-16
ES2222588T3 (es) 2005-02-01
CA2455416C (fr) 2010-11-02
ES2347878T3 (es) 2010-11-22
EP0975640B1 (fr) 2004-06-30
EP1764368A1 (fr) 2007-03-21
FR2761990A1 (fr) 1998-10-16
EP0975640A1 (fr) 2000-02-02
DE122010000054I1 (de) 2011-05-05
WO1998045301A1 (fr) 1998-10-15
CA2665949A1 (fr) 1998-10-15
LU91769I2 (fr) 2011-02-22

Similar Documents

Publication Publication Date Title
FR10C0045I2 (fr) Derive halogene antimitotique d'alcaloide de vinca
SE7508332L (sv) Sett att framstella 3-kinolin-karboxylsyraderivat och anvendning derav som lekemedel.
ES538933A0 (es) Un procedimiento para preparar imidazo(1,2-c)pirimidinas
ES532836A0 (es) Metodo para preparar derivados de acidos b-carbolin-3-barboxilicos
KR870010027A (ko) 벤조티아지논 유도체의 제조 방법
ATE44742T1 (de) Verfahren zur herstellung von ergoline n-methyl- derivaten.
KR850004760A (ko) 이미다조 퀴놀린 유도체의 제조방법
NO873131D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8-(lavere alkyl)-bicyclo-(4.2.0)-octanderivater.
FI853643L (fi) Nytt foerfarande foer framstaellning av 4h-1,2,4-triazolderivat.
JPS5564592A (en) Thiazolo 3, 2-a pyrimidine derivative, its preparation, and drug comprising it
FI851353L (fi) Foerfarande foer syntetisering av estrar.
JPS5718680A (en) Indole derivative
JPS5634674A (en) Isoxazolin-3-one derivative
JPS5583766A (en) Isoxazolin-3-one derivative
KR840009112A (ko) 세펨화합물의 제조방법
JPS5246097A (en) Method of preparing pyrrlobenzodiazpins or acid addition salts thereof
JPS57183791A (en) Imidazopyrazine derivative
JPS51113890A (en) Method for preparing novel cephalosporins
JPS5476577A (en) 1-acylindoline derivative
JPS54138600A (en) Benzo-azabicyclo3,3,1-nonane derivative
JPS52142066A (en) Isooxazolium salts and their preparation